A man with real, symptomatic testosterone deficiency who starts properly guided therapy usually regains libido, improves mood and fitness, and the latest large studies have dispelled long-standing concerns about heart safety (Lincoff et al., New England Journal of Medicine, 2023). Despite this , some men who meet the criteria for diagnosis still do not receive the treatment recommended by the guidelines (Endocrine Society, 2018). This is a real clinical problem , not a temporary fad.
Andropause, also called late hypogonadism, is sometimes described with excessive caution, as if the very idea of treatment is suspicious. Meanwhile , in a man with a confirmed deficiency , it is a treatable condition, and androgen therapy is his recognized condition. first-line option (Endocrine Society guidelines , JCEM, 2018).
Andropause is not an invention, it is a treatable deficiency
Late-onset hypogonadism means a situation in which an aging man, often with concomitant obesity or chronic diseases , develops low testosterone along with symptoms (Huhtaniemi, Asian Journal of Andrology, 2014). Typically , these are decreased libido, erectile dysfunction, fatigue, low mood, loss of muscle mass, anemia , and poorer bone density .
The difference from the narrative that threatens with therapy is simple. It is a recognizable syndrome with specific criteria and effective treatment, and not an inevitable sentence of age that must be accepted. The diagnosis is made in men with symptoms and repetitively low morning testosterone levels (Endocrine Society, patient material ).
What the therapy gives , hard evidence of effectiveness
The best-planned set of studies on testosterone in older men, the so-called Testosterone Trials, included 790 men over 65 years of age with confirmed low testosterone (Snyder et al., New England Journal of Medicine, 2016). Raising hormone levels to the range typical of young men was associated with significant improvements in sexual activity , desire , and erectile function , as well as better mood and less severity of depressive symptoms (Snyder et al., 2016).
The benefits don't end in the sexual realm . The therapy corrected anemia and increased bone density and strength (Testosterone Trials review , 2020; Snyder et al., JAMA Internal Medicine, 2017). The position of the Endocrine Society puts it bluntly, in men diagnosed with permanently low testosterone , treatment is safe and may be effective (Endocrine Society).
Safety, as the TRAVERSE study finally showed
For years, testosterone therapy has been burdened by heart concern , based on small and inconsistent studies. It was decided by TRAVERSE, the largest randomized trial with a placebo group , involving more than 5,000 men with hypogonadism and cardiovascular disease or its high risk (Lincoff et al., New England Journal of Medicine, 2023).
The result was reassuring. The therapy proved to be no worse than placebo in terms of serious cardiac events and did not increase prostate cancer diagnoses (Lincoff et al., 2023). The European panel of experts concluded, that the TRAVERSE data provide robust evidence that testosterone treatment does not increase the risk of serious cardiac events, consistent with previous meta-analyses (European Expert Panel for Testosterone Research, Andrology, 2025).
Like any effective therapy, testosterone treatment is carried out with routine monitoring, for example , of morphology, and this is what specialist care provides . The minor signals noted in the study are predictable and controlled as part of medical surveillance (European Expert Panel, 2025). Surveillance is therefore not an obstacle, but an element that keeps therapy safe.
Why Many Men Still Don't Get Treatment
The problem tends to be the opposite of what the panic around abuse suggests . The Endocrine Society points out that some men with hypogonadism do not receive the treatment they need (Endocrine Society, 2018). This is due to several things, Outdated heart fears , shame before bringing up the topic and attributing symptoms only to age.
The alternative that discouraged men reach for is the worst possible . Testosterone booster supplements and the hormone gray area work without diagnosis, without dose control , and without safety monitoring . It's the exact opposite of What is the effect of properly conducted therapy at the doctor's.
The role of specialist care
Well-conducted testosterone treatment is the domain of an endocrinologist, urologist or men's health clinic . Such an entity confirms the diagnosis, excludes reversible causes, relies on symptoms and repeated morning testosterone tests , selects the form of the drug and monitors response and safety parameters (Endocrine Society guidelines , 2018).
This is the real value of professional care. Proper qualification and supervision make the therapy both effective and safe, which distinguishes legal treatment from independent experimentation. The Endocrine Society emphasizes reliable diagnostics and monitoring plan as a sign of good practice (Endocrine Society, 2018).
When to seek help
If you have been accompanied by decreased libido, erectile dysfunction, a decrease in energy and mood for a long time , you do not need to put up with it or dismiss it as a natural course of things. A reasonable step is to visit a specialist and have your testosterone test taken in the morning , repeated for certainty (Snyder et al., 2016; Endocrine Society guidelines, 2018). If studies confirm a deficiency, there is an effective treatment whose safety has been confirmed by large controlled studies .
Andropause is not a marketing invention or a reason to give up. For a man with real testosterone deficiency , it is a treatable condition, and the way to improvement is through professional diagnosis and therapy, not through supplements from the Internet.
